C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2001
11/07/2001	EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
11/07/2001	EP1151002A1 Antibodies specific to kdr and uses thereof
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150714A2 Methods for inhibiting brain tumor growth
11/07/2001	EP1150691A2 Novel antisense inhibition of rad51
11/07/2001	EP1150688A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
11/07/2001	EP0975380B1 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
11/07/2001	EP0912901B1 Method and reagent for monitoring blood levels of antiplatelet compounds
11/07/2001	EP0845007B1 Pharmaceutical composition containing inhibitors of interferon-gamma
11/07/2001	EP0712497B1 Reagents and methods for the detection and quantification of testosterone in fluid samples
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
11/07/2001	CN1320702A Polypeptide-human ATP-dependent serine proteinase 79 and polynucleotide for coding it
11/07/2001	CN1320700A Polypeptide-human ATP-dependent serine proteinase 15 and polynucleotide for coding it
11/07/2001	CN1320696A Polypeptide-human calcineurin Al subunit 11 and polynucleotide for coding it
11/07/2001	CN1320695A Polypeptide-human phosphatidase 12 and polynucleotide for coding it
11/07/2001	CN1320694A Polypeptide-human YSK1 protein kinase 9 and polynucleotide for coding it
11/07/2001	CN1320690A Polypeptide-human malate dehydrogenase MDH1-22 and polynucleotide for coding it
11/07/2001	CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide
11/07/2001	CN1320642A Polypeptide-human zinc finger protein 28 and polynucleotide for coding it
11/07/2001	CN1320640A Polypeptide-human III-type main tissue compatible protein compound 11 and polynucleotide for coding it
11/07/2001	CN1320638A Polypeptide-human apoptosis regulatory protein 11 and polynucleotide for coding it
11/07/2001	CN1320633A Polypeptide-human movin-like protein 14 and polynucleotide for coding it
11/07/2001	CN1320628A Polypeptide-human alpha-catenin associated protein 9 and polynucleotide for coding it
11/07/2001	CN1320627A Polypeptide-human renal cancer RAGE4 antigen 22 and polynucleotide for coding it
11/07/2001	CN1320620A Polypeptide-human Pax protein 19 and polynucleotide for coding it
11/07/2001	CN1320612A Human vesicular monoamine transporter and its coding sequence
11/07/2001	CN1320609A Polypeptide-CYP-60-18 and polynucleotide for coding it
11/07/2001	CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313378 Transgenic plant for use in biological pest control
11/06/2001	US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it
11/06/2001	US6313274 Subjecting to ultraviolet radiation to reduce some disulfide bonds and generate thiol moieties; reacting with antibody, ultraviolet radiation to reduce some disulfide bonds and reacting with chemical; labeling antibodies
11/06/2001	US6313270 DbpB
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313267 Calcium-binding proteins
11/06/2001	US6313263 γ, δ T cell receptor and methods for detection
11/06/2001	US6313096 Inhibitors of trypsin-like enzymes
11/06/2001	US6312944 Nucleotide sequences coding microorganism poylpeptide; fo r use as diagnostic tool in genetic engineering
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases
11/06/2001	US6312922 Complementary DNAs
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312901 Spatially addressable, cleavable reflective signal elements, assay device and method
11/06/2001	US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
11/06/2001	US6312700 Fusion proteins and receptors
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
11/06/2001	US6312693 Antibodies against human CD40
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/06/2001	US6312691 Treating tumors
11/06/2001	US6312690 Monoclonal recombinant anti-rhesus D (D7C2) antibody
11/06/2001	US6312689 Antibodies or antigens
11/06/2001	US6312688 Tyrosine-phosphatase-related protein
11/01/2001	WO2001081928A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	WO2001081927A1 Method of detecting streptococcus sobrinus and antibody therefor
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081579A1 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081544A2 Identification and uses of a hyaluronan receptor
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081424A1 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
11/01/2001	WO2001081423A1 Antibodies against native gp96, production and use thereof
11/01/2001	WO2001081422A1 Secretory tyrosine phosphatases from mycobacteria
11/01/2001	WO2001081421A2 Synthetic peptides that bind to the hepatitis b virus core and e antigens
11/01/2001	WO2001081417A2 Use of taci as an anti-tumor agent
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081414A2 Integrin alpha subunit and uses thereof
11/01/2001	WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081380A2 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	WO2001080904A2 Means for diagnosing and treating carcinomas
11/01/2001	WO2001080889A1 Product and process for regulation of t cell responses
11/01/2001	WO2001080888A2 Method for treatment of tumors using photodynamic therapy
11/01/2001	WO2001080885A2 Equine protozoal myeloencephalitis vaccine
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080883A1 Bispecific molecules and uses thereof
11/01/2001	WO2001080881A1 Vaccine comprising a tick cement protein
11/01/2001	WO2001080880A2 Apoptotic agents
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001042306A3 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization
11/01/2001	WO2001038484A3 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034807A3 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2?
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001034634A8 Tumor suppressor molecules and methods of use
11/01/2001	WO2001021791A3 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides
11/01/2001	WO2000053757A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	US20010036911 Detergent compositions comprising benefit agents
11/01/2001	US20010036663 Selective expansion of target cell populations

1 ... 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 ... 1494